These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16828590)

  • 1. Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.
    Kuchulakanti PK; Chu WW; Torguson R; Clavijo L; Wolfram R; Mishra S; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2006 Jul; 98(2):187-92. PubMed ID: 16828590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery.
    Stankovic G; Cosgrave J; Chieffo A; Iakovou I; Sangiorgi G; Montorfano M; Airoldi F; Carlino M; Michev I; Finci L; Colombo A
    Am J Cardiol; 2006 Aug; 98(3):362-6. PubMed ID: 16860024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
    Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
    Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year outcomes from the TAXUS express stent versus cypher stent.
    Mayor M; Malik AZ; Minor RJ; Deshpande MC; Strauss WE; Maloney TH; Baim DS; O'Neill W; Kandzari DE
    Am J Cardiol; 2009 Apr; 103(7):930-6. PubMed ID: 19327418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.
    Trabattoni D; Fabbiocchi F; Montorsi P; Ravagnani P; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):415-21. PubMed ID: 17722020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes and thrombosis rates of sirolimus-eluting versus paclitaxel-eluting stents in an unselected population with coronary artery disease (REWARDS registry).
    Waksman R; Buch AN; Torguson R; Xue Z; Smith K; Javaid A; Chu WW; Satler LF; Kent KM; Pichard AD;
    Am J Cardiol; 2007 Jul; 100(1):45-51. PubMed ID: 17599439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
    Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
    Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation.
    Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J
    Am Heart J; 2008 Mar; 155(3):553-61. PubMed ID: 18294496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents.
    Burzotta F; Siviglia M; Altamura L; Trani C; Leone AM; Romagnoli E; Mazzari MA; Mongiardo R; Niccoli G; Brancati M; Biondi-Zoccai G; Rebuzzi AG; Schiavoni G; Crea F
    Am J Cardiol; 2007 Feb; 99(3):364-8. PubMed ID: 17261399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
    Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
    Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W
    Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
    Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.
    Mahmoudi M; Delhaye C; Wakabayashi K; Ben-Dor I; Gonzalez MA; Maluenda G; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2011 Jun; 107(12):1757-62. PubMed ID: 21497782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
    Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB;
    Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term angiographic outcomes of sirolimus- and paclitaxel-eluting stent placement in diabetes, long lesions, and small vessels.
    Nakano Y; Ishikawa T; Mutoh M
    Cardiovasc Interv Ther; 2015 Oct; 30(4):327-37. PubMed ID: 25673511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease.
    Lee MS; Jamal F; Kedia G; Chang G; Kapoor N; Forrester J; Czer L; Zimmer R; DeRobertis M; Trento A; Makkar RR
    Int J Cardiol; 2007 Dec; 123(1):34-42. PubMed ID: 17292983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
    Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents.
    Kitabata H; Loh JP; Pendyala LK; Badr S; Dvir D; Barbash IM; Minha S; Torguson R; Chen F; Satler LF; Suddath WO; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2013 Oct; 112(8):1093-8. PubMed ID: 23827397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.
    Kim MH; Hong SJ; Cha KS; Park HS; Chae SC; Hur SH; Gwon HC; Bae JH; Lim DS
    J Interv Cardiol; 2008 Jun; 21(3):225-31. PubMed ID: 18341520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.